tiprankstipranks
Trending News
More News >
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Ratios

Compare
0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Ratios

JP:4886's free cash flow for Q3 2024 was ¥0.49. For the 2024 fiscal year, JP:4886's free cash flow was decreased by ¥ and operating cash flow was ¥0.12. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.54 2.34 3.05 3.10 2.39
Quick Ratio
1.39 1.49 2.04 2.15 1.53
Cash Ratio
0.46 0.57 0.82 0.76 0.63
Solvency Ratio
0.23 0.35 0.23 0.21 0.16
Operating Cash Flow Ratio
0.11 0.06 0.19 0.18 0.39
Short-Term Operating Cash Flow Coverage
0.56 0.30 0.97 1.65 2.47
Net Current Asset Value
¥ 26.71B¥ 27.33B¥ 21.15B¥ 15.15B¥ 1.86B
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.10 0.14 0.17 0.20
Debt-to-Equity Ratio
0.17 0.15 0.23 0.29 0.37
Debt-to-Capital Ratio
0.14 0.13 0.19 0.22 0.27
Long-Term Debt-to-Capital Ratio
0.09 0.07 0.14 0.20 0.24
Financial Leverage Ratio
1.54 1.47 1.60 1.70 1.86
Debt Service Coverage Ratio
1.64 2.04 2.04 3.26 2.26
Interest Coverage Ratio
104.57 162.50 102.16 85.63 61.19
Debt to Market Cap
0.17 0.16 0.38 0.39 0.40
Interest Debt Per Share
386.38 336.42 448.78 497.07 579.96
Net Debt to EBITDA
0.04 -0.34 -0.23 0.25 0.84
Profitability Margins
Gross Profit Margin
48.86%48.80%47.28%46.55%46.00%
EBIT Margin
9.74%15.76%8.94%10.99%6.54%
EBITDA Margin
13.24%20.00%13.62%13.57%12.63%
Operating Profit Margin
8.31%10.34%8.45%8.47%6.54%
Pretax Profit Margin
9.65%15.69%8.86%10.89%6.48%
Net Profit Margin
7.95%12.01%7.01%7.58%4.92%
Continuous Operations Profit Margin
7.95%12.01%7.01%7.58%4.92%
Net Income Per EBT
82.38%76.51%79.11%69.61%75.89%
EBT Per EBIT
116.11%151.72%104.87%128.53%99.03%
Return on Assets (ROA)
5.07%8.31%4.86%5.15%3.29%
Return on Equity (ROE)
7.81%12.18%7.77%8.77%6.10%
Return on Capital Employed (ROCE)
6.87%9.73%7.35%7.13%5.48%
Return on Invested Capital (ROIC)
5.35%6.93%5.54%4.84%4.00%
Return on Tangible Assets
5.45%8.59%5.13%5.56%3.84%
Earnings Yield
7.81%12.34%12.62%11.97%6.55%
Efficiency Ratios
Receivables Turnover
4.25 4.03 3.97 3.91 4.20
Payables Turnover
3.59 4.37 11.23 9.70 4.62
Inventory Turnover
1.25 1.58 1.80 2.01 2.07
Fixed Asset Turnover
3.43 5.58 5.60 5.18 4.35
Asset Turnover
0.64 0.69 0.69 0.68 0.67
Working Capital Turnover Ratio
1.90 1.84 1.74 2.00 2.54
Cash Conversion Cycle
277.11 238.48 261.89 237.45 183.98
Days of Sales Outstanding
85.87 90.48 91.86 93.38 87.00
Days of Inventory Outstanding
293.01 231.42 202.53 181.69 176.04
Days of Payables Outstanding
101.77 83.43 32.50 37.62 79.07
Operating Cycle
378.88 321.91 294.39 275.07 263.05
Cash Flow Ratios
Operating Cash Flow Per Share
87.66 52.48 118.67 100.18 230.55
Free Cash Flow Per Share
-16.76 1.17 92.25 16.39 191.64
CapEx Per Share
104.42 51.32 26.42 83.79 38.91
Free Cash Flow to Operating Cash Flow
-0.19 0.02 0.78 0.16 0.83
Dividend Paid and CapEx Coverage Ratio
0.59 0.66 2.80 1.02 4.12
Capital Expenditure Coverage Ratio
0.84 1.02 4.49 1.20 5.92
Operating Cash Flow Coverage Ratio
0.23 0.16 0.27 0.20 0.40
Operating Cash Flow to Sales Ratio
0.04 0.02 0.06 0.05 0.12
Free Cash Flow Yield
-0.73%0.05%7.76%1.30%13.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.80 8.11 7.92 8.35 15.28
Price-to-Sales (P/S) Ratio
1.02 0.97 0.56 0.63 0.75
Price-to-Book (P/B) Ratio
1.00 0.99 0.62 0.73 0.93
Price-to-Free Cash Flow (P/FCF) Ratio
-137.50 1.85K 12.89 77.06 7.62
Price-to-Operating Cash Flow Ratio
26.28 41.15 10.02 12.61 6.34
Price-to-Earnings Growth (PEG) Ratio
-0.39 0.10 -10.51 0.14 0.05
Price-to-Fair Value
1.00 0.99 0.62 0.73 0.93
Enterprise Value Multiple
7.73 4.53 3.85 4.92 6.79
Enterprise Value
65.61B 56.90B 31.69B 37.77B 47.33B
EV to EBITDA
7.73 4.53 3.85 4.92 6.79
EV to Sales
1.02 0.91 0.52 0.67 0.86
EV to Free Cash Flow
-138.13 1.72K 12.17 81.24 8.71
EV to Operating Cash Flow
26.40 38.29 9.46 13.29 7.24
Tangible Book Value Per Share
2.19K 2.09K 1.77K 1.51K 1.15K
Shareholders’ Equity Per Share
2.30K 2.19K 1.93K 1.72K 1.57K
Tax and Other Ratios
Effective Tax Rate
0.18 0.23 0.21 0.30 0.24
Revenue Per Share
2.26K 2.22K 2.14K 2.00K 1.94K
Net Income Per Share
179.94 266.49 150.08 151.22 95.63
Tax Burden
0.82 0.77 0.79 0.70 0.76
Interest Burden
0.99 1.00 0.99 0.99 0.99
Research & Development to Revenue
0.11 0.08 0.07 0.06 0.00
SG&A to Revenue
0.00 0.21 0.22 0.22 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.49 0.20 0.63 0.46 2.41
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis